Honduran Comayagua Coffee (Coffea arabica 'Honduran Comayagua')

Honduran Comayagua Coffee (Coffea arabica 'Honduran Comayagua') is a regional arabica cultivar grown in Honduras's Comayagua department, deriving its primary bioactive activity from caffeine (1.2–1.5%) and chlorogenic acids. These compounds act as adenosine receptor antagonists and antioxidant polyphenols respectively, though no clinical research has isolated effects specific to this cultivar variant.

Origin & History

Honduran Comayagua Coffee is a cultivar variant of Coffea arabica grown in central Honduras's Comayagua region at 1,000-1,500 meter elevations, featuring varieties like Typica, Bourbon, and Catuai. The beans are processed through washed, honey, or natural fermentation methods, yielding medium to large oval beans (screen size 15-18) containing 1.2-1.5% caffeine by weight.

Historical & Cultural Context

Honduran Comayagua Coffee has no documented use in traditional medicine systems according to available sources. It is valued as a modern specialty coffee for commercial export, achieving 80-90+ SCA cupping scores for sensory qualities like chocolate/citrus flavors and creamy body rather than medicinal applications.

Health Benefits

• No clinical evidence exists for health benefits specific to this cultivar variant
• General Coffea arabica effects stem from caffeine content (1.2-1.5%) but are not studied for this regional variant
• Contains 10-15% fats and 11-12% proteins typical of arabica coffee
• Rich in carbohydrates (50-60%) but biomedical effects unstudied
• No human trials, RCTs, or meta-analyses identified for this specific cultivar

How It Works

Caffeine in Honduran Comayagua Coffee competitively antagonizes adenosine A1 and A2A receptors in the central nervous system, reducing neural inhibition and increasing dopamine and norepinephrine signaling. Chlorogenic acids, particularly 5-caffeoylquinic acid, inhibit glucose-6-phosphatase activity and modulate glucose absorption in the gut, contributing to glycemic regulation observed in general arabica studies. Coffee lipids such as cafestol and kahweol, present in the 10–15% fat fraction, act as ligands for the pregnane X receptor (PXR), influencing bile acid and cholesterol metabolism.

Scientific Research

No clinical trials, RCTs, or meta-analyses specific to Honduran Comayagua Coffee were identified in PubMed-indexed studies. The available research focuses exclusively on agronomic, sensory, and processing characteristics rather than biomedical applications. All sources address cultivation and flavor profiles without human health data.

Clinical Summary

No clinical trials exist specifically examining Honduran Comayagua Coffee as a distinct cultivar; all available evidence is extrapolated from general Coffea arabica research. Large observational cohort studies involving hundreds of thousands of participants associate regular arabica coffee consumption (3–5 cups/day) with reduced risk of type 2 diabetes and Parkinson's disease, though causality is not firmly established. Randomized controlled trials on arabica-derived chlorogenic acid extracts (doses of 120–300 mg/day) have demonstrated modest reductions in systolic blood pressure of 5–10 mmHg in hypertensive adults. The cultivar-specific composition of Comayagua-region beans—including altitude-influenced chlorogenic acid concentrations—has not been independently quantified or studied in human subjects.

Nutritional Profile

Honduran Comayagua Coffee (Coffea arabica 'Honduran Comayagua') shares the general green/roasted arabica nutritional framework with regional terroir influences. Macronutrients per 100g green bean: carbohydrates 50-60% (primarily sucrose 6-9% in green bean, degrading significantly during roasting; polysaccharides including arabinogalactans and mannans comprising 35-45%); lipids 10-15% (predominantly linoleic acid ~40% of fatty acid fraction, palmitic acid ~35%, oleic acid ~10%, with diterpenes cafestol and kahweol at approximately 0.5-1.0% of total lipid fraction — relevant as bioactive compounds with reported cholesterol-modulating effects); proteins 11-12% (rich in free amino acids including glutamic acid, aspartic acid, and alanine which contribute to Maillard reaction products during roasting). Roasted bean per standard 7g serving dose: calories ~2 kcal (negligible when consumed as brewed beverage). Brewed coffee (240ml): caffeine 80-120mg estimated based on arabica average of 1.2-1.5% caffeine in dry bean; chlorogenic acids (CGA) 70-200mg per cup, primarily 5-caffeoylquinic acid (5-CQA), representing the dominant polyphenol class with antioxidant and potential glucose-metabolism-modulating properties; trigonelline 60-90mg per cup (partially converted to niacin/vitamin B3 during roasting, yielding approximately 0.5-1.0mg niacin equivalent per cup); magnesium 7-10mg per 240ml serving; potassium 100-120mg per 240ml serving; niacin (B3) 0.5-1.0mg per cup post-roast conversion. Bioavailability notes: CGAs have moderate bioavailability (~30% absorbed in small intestine, remainder fermented by colonic microbiota); cafestol and kahweol are largely retained in paper-filtered brewing methods at negligible levels but present in unfiltered preparations (French press, espresso) at physiologically relevant concentrations; caffeine bioavailability is near-complete (~99% absorbed). Comayagua valley-specific terroir (altitude 1,000-1,500 masl, volcanic loam soils) may influence sucrose accumulation and CGA concentration relative to lower-altitude arabica variants, though no published compositional analysis specific to this cultivar designation has been identified — values extrapolated from Honduran SHG (Strictly High Grown) arabica compositional data.

Preparation & Dosage

No clinically studied dosage ranges exist for Honduran Comayagua Coffee in extract, powder, or standardized forms. General arabica coffee yields approximately 95mg caffeine per 8oz brewed cup based on 1.2-1.5% caffeine content in beans. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

General Coffea arabica, L-theanine, Green tea extract, Rhodiola rosea, Ginseng

Safety & Interactions

Caffeine intake exceeding 400 mg/day (roughly 4–5 standard cups) is associated with anxiety, insomnia, tachycardia, and elevated blood pressure, and sensitive individuals may experience effects at lower doses. Caffeine inhibits CYP1A2 metabolism and can potentiate stimulant medications such as ephedrine and interact with anticoagulants like warfarin by altering clotting factor metabolism. Unfiltered preparations retaining cafestol and kahweol are contraindicated in individuals with hypercholesterolemia, as these diterpenes raise LDL cholesterol by up to 6–8% with habitual consumption. Pregnant individuals are advised to limit caffeine to under 200 mg/day per major obstetric guidelines, as higher intake is associated with increased risk of low birth weight and miscarriage.